NVAX NASDAQ
Credit Risk of going bust: higher than 67% of companies Debt: 16.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.23 (down 98%), Novavax, Inc. would be worth roughly what it owes.
Total debt $295.6M against a stock market value of $1.55B.
Distance to default 3.65 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $144.9M (short-term plus half of long-term), stock volatility 68.7%; Altman Z'' -14.52. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Gaithersburg, MD 20878
US
Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal quadrivalent influenza vaccine in Phase 3 clinical trials. Furthermore, Novavax is advancing ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine, which is in Phase II clinical trials for adults aged 60 and older, and in Phase I for pediatric use. The company holds a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of its COVID-19 vaccine candidate, NVX-CoV2373. Established in 1987, Novavax, Inc. is headquartered in Gaithersburg, Maryland.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Rodgers Richard J | M-Exempt | 18,880 | — | 2026-06-20 |
| Rodgers Richard J | M-Exempt | 18,880 | — | 2026-06-20 |
| King Rachel K. | M-Exempt | 18,880 | — | 2026-06-20 |
| King Rachel K. | M-Exempt | 18,880 | — | 2026-06-20 |
| DOUGLAS RICHARD | M-Exempt | 18,880 | — | 2026-06-20 |